Dr. David Samadi Sheds More Light On Prostate Cancer Treatment.
Wn.com has a chance to meet Dr. David Samadi, an oncologist, and share more about the prostrate prognosis after the successful treatment of Mitt Romney who was diagnosed with cancer in 2017. This was after Mitt Romney announced to have undergone a prostate surgery for a gradually growing tumor that was realized early in 2017. Mitt had the surgery done on him last summer by Dr. Thomas Ahlering in California at UC Irvine hospital. He was among the 161,360 men in 2017 that were diagnosed with prostate cancer. According to Dr. Samadi, about 164,690 new prostate cancer cases is the number estimated by the American Cancer Society to be confirmed in 2018.
Mitt Romney discloser of his past health condition is argued to a likely alert of his interest to be running for the Utah Senate seat which is to be soon left by Orrin Hatch.
Dr. Samadi says that Prostate cancer is more common in old men. It is a rare case for men aged below 40. An estimate of 6 out of 10 men is diagnosed with cancer at the age of 65 and above. Mitt Romney is one such case, who was diagnosed with the disease at the age of 70, adds Samadi.
Once a man is diagnosed with prostate cancer, he is left with the responsibility of choosing whether to be treated with radiation or surgery. On that matter, Samadi always ensures that he has a discussion with the patient on the pros and cons of both treatments so that they may have an understanding of what awaits them.
Samadi says that in case of cancer hasn’t spread beyond the prostate, a surgery is highly recommended. The several studies conducted on prostate cancer treatment shows that prostate cancer patients respond better to surgery as compared to radiation.
There are several reasons why Dr. Samadi prefers surgery over radiation which includes:
There is twice as high a likelihood of a patient dying from prostate cancer after undergoing radiation treatment also radiation-treated patients are likely to die 1.5 times faster than their counterparts.
Radiation exposes men to developing secondary cancer, due to the treatment’s side effects. Treating secondary cancer after radiation is very hard, reducing their survival rate.
Samadi finds it very important for patients to dig into the experience of the oncologist they are dealing with.
Samadi is the Chief of Robotic Surgery and chairman of Urology at Lenox Hill Hospital. He holds a degree in Biochemistry from Stony Brook University and a degree in medicine from the same university. He went to Einstein College of Medicine and Montefiore Medical Center for Urology studies. He has gained great expertise in the field and is recognized as one of the best practitioners of Urology.